Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
ECO
Apr 20, 2024, 07:23 |
Societies
Join the ASCO Advocacy Summit action virtually using the ACT Network
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: “Join the ASCO Advocacy…
Apr 20, 2024, 06:18 |
Insight
New Paper Alert! Addressing BRAF V600E in Metastatic Non-Small Cell Lung Cancer
Addressing BRAF V600E in Metastatic Non-Small Cell Lung Cancer Authors: David Planchard, Rachel E. Sanborn,…
Apr 20, 2024, 06:03 |
Insight
Toni Choueiri: The long-awaited OS results from KEYNOTE-564 are out at the New England Journal of Medicine!
Toni Choueiri shared on X/Twitter: "The long-awaited OS results from KEYNOTE-564 are out at the New…
Apr 20, 2024, 05:49 |
Blog
Fumiko Ladd Chino: Making a Difference: ASCO Advocacy Summit Amplifies Patient Voices in DC
Fumiko Ladd Chino shared on X/Twitter: "ASCO Advocacy Champion I am proud to be in…
Apr 20, 2024, 01:08 |
Insight
Oligometastatic esophagogastric cancer (OMEC-4) paper summary by Erman Akkus
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Oligometastatic esophagogastric cancer (OMEC-4):…
Apr 19, 2024, 20:03 |
Insight
Piotr Wysocki: BRCA1/2 mutations represent a poor prognostic factor for mCRCP patients - underscoring the need to use PARPi as soon as possible
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 19, 2024, 17:58 |
Drugs
Fumiko Ladd Chino: We want lawmakers to end drug shortages
Fumiko Ladd Chino shared a post on X: "I am here in DC ASCO Advocacy…
Apr 19, 2024, 16:30 |
Insight
New Paper Alert! Outcomes of high-risk individuals undergoing pancreatic cancer surveillance
Effective Surveillance Strategies for High-Risk Pancreatic Cancer Individuals Authors: Aleksander M. Bogdanski, Jeanin E. van…
Apr 19, 2024, 15:52 |
Drugs
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer based on ALINA trial
FDA, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following…
Apr 19, 2024, 15:14 |
Dialogues
Beyond The Cancer Diagnosis: Psycho-Oncological Aspects Of Kate Middleton’s Diagnosis
In this episode of 'Beyond the Cancer Diagnosis' Adrian Pogacian discusses the challenges and the…
312
313
314
315
316
All:
4500
Posts:
3131 - 3140
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube